Eric J Vallender1, Dharmendra B Goswami2, Nina M Shinday3, Susan V Westmoreland4, Wei-Dong Yao5, James K Rowlett6. 1. Harvard Medical School, New England Primate Research Center, Southborough, MA 01772, United States; University of Mississippi Medical Center, Jackson, MS 39216, United States; Tulane National Primate Research Center, Covington, LA 70433, United States. Electronic address: evallender@umc.edu. 2. Harvard Medical School, New England Primate Research Center, Southborough, MA 01772, United States; Boston University, Boston, MA 02118, United States. 3. Harvard Medical School, New England Primate Research Center, Southborough, MA 01772, United States; University of Massachusetts-Amherst, Amherst, MA 01003, United States. 4. Harvard Medical School, New England Primate Research Center, Southborough, MA 01772, United States. 5. Harvard Medical School, New England Primate Research Center, Southborough, MA 01772, United States; SUNY Upstate Medical University, Syracuse, NY 13210, United States. 6. Harvard Medical School, New England Primate Research Center, Southborough, MA 01772, United States; University of Mississippi Medical Center, Jackson, MS 39216, United States; Tulane National Primate Research Center, Covington, LA 70433, United States; University of Massachusetts-Amherst, Amherst, MA 01003, United States.
Abstract
BACKGROUND: The behavioral consequences associated with addiction are thought to arise from drug-induced neuroadaptation. The mesolimbic system plays an important initial role in this process, and while the dopaminergic system specifically has been strongly interrogated, a complete understanding of the broad transcriptomic effects associated with cocaine use remains elusive. METHODS: Using next generation sequencing approaches, we performed a comprehensive evaluation of gene expression differences in the ventral tegmental area and nucleus accumbens of rhesus macaques that had self-administered cocaine for roughly 100days and saline-yoked controls. During self-administration, the monkeys increased daily consumption of cocaine until almost the maximum number of injections were taken within the first 15min of the one hour session for a total intake of 3mg/kg/day. RESULTS: We confirm the centrality of dopaminergic differences in the ventral tegmental area, but in the nucleus accumbens we see the strongest evidence for an inflammatory response and large scale chromatin remodeling. CONCLUSIONS: These findings suggest an expanded understanding of the pathology of cocaine addiction with the potential to lead to the development of alternative treatment strategies.
BACKGROUND: The behavioral consequences associated with addiction are thought to arise from drug-induced neuroadaptation. The mesolimbic system plays an important initial role in this process, and while the dopaminergic system specifically has been strongly interrogated, a complete understanding of the broad transcriptomic effects associated with cocaine use remains elusive. METHODS: Using next generation sequencing approaches, we performed a comprehensive evaluation of gene expression differences in the ventral tegmental area and nucleus accumbens of rhesus macaques that had self-administered cocaine for roughly 100days and saline-yoked controls. During self-administration, the monkeys increased daily consumption of cocaine until almost the maximum number of injections were taken within the first 15min of the one hour session for a total intake of 3mg/kg/day. RESULTS: We confirm the centrality of dopaminergic differences in the ventral tegmental area, but in the nucleus accumbens we see the strongest evidence for an inflammatory response and large scale chromatin remodeling. CONCLUSIONS: These findings suggest an expanded understanding of the pathology of cocaine addiction with the potential to lead to the development of alternative treatment strategies.
Authors: Wei Lin; Emmanouil Metzakopian; Yannis E Mavromatakis; Nan Gao; Nikolaos Balaskas; Hiroshi Sasaki; James Briscoe; Jeffrey A Whitsett; Martyn Goulding; Klaus H Kaestner; Siew-Lan Ang Journal: Dev Biol Date: 2009-07-14 Impact factor: 3.582
Authors: Michael J Bannon; Candace L Savonen; Zachary J Hartley; Magen M Johnson; Carl J Schmidt Journal: PLoS One Date: 2015-02-06 Impact factor: 3.240
Authors: Hae-Min Park; Rosalba Satta; Roderick G Davis; Young Ah Goo; Richard D LeDuc; Ryan T Fellers; Joseph B Greer; Elena V Romanova; Stanislav S Rubakhin; Rex Tai; Paul M Thomas; Jonathan V Sweedler; Neil L Kelleher; Steven M Patrie; Amy W Lasek Journal: J Proteome Res Date: 2019-10-02 Impact factor: 4.466
Authors: Hilary R Smith; Thomas J R Beveridge; Susan H Nader; Michael A Nader; Linda J Porrino Journal: Brain Struct Funct Date: 2019-02-12 Impact factor: 3.270
Authors: R Christopher Pierce; Bruno Fant; Sarah E Swinford-Jackson; Elizabeth A Heller; Wade H Berrettini; Mathieu E Wimmer Journal: Neuropsychopharmacology Date: 2018-02-05 Impact factor: 7.853
Authors: Soheil Kazemi Roodsari; Yan Cheng; Kirstin M Reed; Laurie L Wellman; Larry D Sanford; Woong-Ki Kim; Ming-Lei Guo Journal: Biomedicines Date: 2022-05-18
Authors: Deena M Walker; Hannah M Cates; Yong-Hwee E Loh; Immanuel Purushothaman; Aarthi Ramakrishnan; Kelly M Cahill; Casey K Lardner; Arthur Godino; Hope G Kronman; Jacqui Rabkin; Zachary S Lorsch; Philipp Mews; Marie A Doyle; Jian Feng; Benoit Labonté; Ja Wook Koo; Rosemary C Bagot; Ryan W Logan; Marianne L Seney; Erin S Calipari; Li Shen; Eric J Nestler Journal: Biol Psychiatry Date: 2018-04-25 Impact factor: 13.382